Northwestern Mutual Wealth Management
KNSA icon

Northwestern Mutual Wealth Management’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$59.7K Buy
934
+892
+2,124% +$46.3K ﹤0.01% 2470
2026
Q1 		$2.02K Buy
+42
New +$1.86K ﹤0.01% 3596

Other funds holding KNSA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM

Northwestern Mutual Wealth Management's KNSA Position: Q2 2026 in Review

Northwestern Mutual Wealth Management increased its Kiniksa Pharmaceuticals (KNSA) stake by 2,124% in Q2 2026, buying an estimated $46.3K and bringing the position to 934 shares worth $59.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2470.

Northwestern Mutual Wealth Management first reported a position in KNSA in Q1 2026 and has held it in 2 quarters since. 266 funds tracked by Wall St. Rank hold KNSA as of Q2 2026.

  • Northwestern Mutual Wealth Management held 934 shares of Kiniksa Pharmaceuticals worth $59.7K as of Q2 2026.
  • Northwestern Mutual Wealth Management bought 892 Kiniksa Pharmaceuticals shares in Q2 2026, an estimated $46.3K.
  • Kiniksa Pharmaceuticals made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q2 2026, its #2470 holding.
  • Northwestern Mutual Wealth Management first reported a position in Kiniksa Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 266 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q2 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.